Yekaterina Chudnovsky - Director, 10%+ Owner at Elicio Therapeutics, Inc.

Issuer-level insider activity

Role: Director, 10%+ Owner
Issuer ticker: ELTX on Nasdaq
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by Yekaterina Chudnovsky since 28 Aug 2025

Reported holdings for Yekaterina Chudnovsky in Elicio Therapeutics, Inc.

Form 4 holding Director, 10%+ Owner

Elicio Therapeutics, Inc.

Security class: Common Stock
Shares / value: 5,416,212
Estimated value: $31,468,192
Report date: 05 Mar 2025
Price: $5.81
Ownership: Held by GKCC, LLC

Form 4 holding Director, 10%+ Owner

Elicio Therapeutics, Inc.

Security class: Pre-Funded Warrants
Shares / value: 1,600,000
Estimated value: $7,984,000
Report date: 28 Jun 2024
Price: $4.99
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director, 10%+ Owner

Elicio Therapeutics, Inc.

Security class: Common Warrants
Shares / value: 1,600,000
Estimated value
Report date: 28 Jun 2024
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director, 10%+ Owner

Elicio Therapeutics, Inc.

Security class: Warrant (right to buy)
Shares / value: 103,225
Estimated value
Report date: 03 Jun 2025
Price
Ownership: Held by GKCC, LLC
Underlying class: Common Stock
Underlying amount

Form 4 holding Director, 10%+ Owner

Elicio Therapeutics, Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 7,900
Estimated value
Report date: 19 May 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Transaction history for Yekaterina Chudnovsky in Elicio Therapeutics, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .